| 1 |
34704355 | High residual inflammation despite HIV viral suppression: Lessons learned from real-time adherence monitoring among people with HIV in Africa. | 2022 May |
1 |
| 2 |
35045162 | Effects of tenofovir on telomeres, telomerase and T cell maturational subset distribution in long-term aviraemic HIV-infected adults. | 2022 Mar 31 |
1 |
| 3 |
34814505 | [Prevalence and related factors of CD4+T lymphocytes immune recovery among adult HIV/AIDS on antiretroviral therapy in Dehong Dai and Jingpo Autonomous Prefecture]. | 2021 Jun 10 |
1 |
| 4 |
30755713 | Epithelial Cells and Fibroblasts from the Human Female Reproductive Tract Accumulate and Release TFV and TAF to Sustain Inhibition of HIV Infection of CD4+ T cells. | 2019 Feb 12 |
2 |
| 5 |
31143861 | A prospective study to evaluate efficacy of second-line antiretroviral therapy given to human immunodeficiency virus patients at Antiretroviral Therapy Plus Centre in India. | 2019 Jan-Jun |
1 |
| 6 |
31597561 | Reasons for first line ART modification over the years during the ART scale up in Uganda. | 2019 Oct 9 |
1 |
| 7 |
29424790 | Differences in Local and Systemic TFV PK Among Premenopausal Versus Postmenopausal Women Exposed to TFV 1% Vaginal Gel. | 2018 May 1 |
1 |
| 8 |
29707599 | Prevalence and Evolution of Renal Impairment in People Living With HIV in Rural Tanzania. | 2018 Apr |
1 |
| 9 |
29850480 | Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults. | 2018 |
2 |
| 10 |
26906233 | Acute myelitis by human herpes virus 7 in an HIV-infected patient. | 2016 Apr |
1 |
| 11 |
27032851 | Clinician compliance with laboratory monitoring and prescribing guidelines in HIV-1-infected patients receiving tenofovir. | 2016 Mar 9 |
1 |
| 12 |
27231099 | Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya. | 2016 |
1 |
| 13 |
27646953 | Immune reconstitution inflammatory syndrome associated with dermatophytoses in two HIV-1 positive patients in rural Tanzania: a case report. | 2016 Sep 20 |
1 |
| 14 |
25247433 | HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trial. | 2015 Jan 1 |
1 |
| 15 |
26157126 | The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment. | 2015 Sep |
2 |
| 16 |
26598082 | Proteinuria is common among HIV patients: what are we missing? | 2015 Oct |
1 |
| 17 |
24296645 | Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa. | 2014 |
1 |
| 18 |
25350130 | Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 study. | 2014 |
4 |
| 19 |
23079810 | Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy. | 2013 Feb 20 |
1 |
| 20 |
23475910 | A case of possible darunavir/ritonavir-induced peripheral neuropathy: case description and review of the literature. | 2013 May-Jun |
1 |
| 21 |
23892239 | HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes. | 2013 Oct 1 |
1 |
| 22 |
22193343 | Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir. | 2012 May |
1 |
| 23 |
21628669 | Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction. | 2011 Jul 1 |
1 |
| 24 |
20233398 | Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy. | 2010 Mar 16 |
2 |
| 25 |
20452889 | Raltegravir, tenofovir, and emtricitabine in an HIV-infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver toxicity. | 2010 Feb 26 |
1 |
| 26 |
20515419 | Prevalence and factors associated with renal dysfunction among HIV-infected patients. | 2010 Jun |
2 |
| 27 |
19398921 | A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression. | 2009 Jul 1 |
1 |
| 28 |
19432547 | Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. | 2009 Jun 1 |
1 |
| 29 |
19737231 | Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine as nucleoside reverse transcription inhibitor backbone. | 2009 Oct |
1 |
| 30 |
18770899 | CD4 count improvement following tenofovir to abacavir switch in a patient with persistent lymphopenia despite an undetectable viral load. | 2008 Aug |
1 |
| 31 |
17177308 | Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study. | 2007 Feb |
1 |
| 32 |
17341536 | CD4+ cell count decline despite HIV suppression: a probable didanosine-valganciclovir interaction. | 2007 Mar |
2 |
| 33 |
17434879 | CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load. | 2007 Jun |
1 |
| 34 |
17926643 | CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. | 2007 |
2 |
| 35 |
16531427 | Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir. | 2006 May |
2 |
| 36 |
16691065 | Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia. | 2006 May 12 |
2 |
| 37 |
16717052 | Comment on: suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir. | 2006 Jul |
1 |
| 38 |
16956530 | [Immunological effectiveness of the nucleoside/nucleotide analog combinations, tenofovir + lamivudine, didanosine + lamivudine and tenofovir + didanosine, in patients with HIV infection and sustained viral suppression]. | 2006 Aug-Sep |
2 |
| 39 |
17127826 | [Renal toxicity in HIV-infected patients receiving HAART including tenofovir]. | 2006 Sep |
1 |
| 40 |
15802975 | Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine. | 2005 Mar 24 |
1 |
| 41 |
15958845 | Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen. | 2005 Jul 1 |
2 |
| 42 |
16107993 | Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies. | 2005 Sep 15 |
1 |
| 43 |
16184059 | Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have a comparable effect on the CD4 cell change after switching to tenofovir-based regimens. | 2005 Oct 14 |
1 |
| 44 |
15090798 | Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load. | 2004 Feb 20 |
2 |
| 45 |
15259896 | Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach. | 2004 Jun |
1 |
| 46 |
15622326 | CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related. | 2004 Dec 3 |
1 |
| 47 |
14498980 | Transient early post-inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut-associated lymphoid tissues in SIVmac239-infected rhesus macaques, but not resistance to rechallenge. | 2003 Aug |
1 |
| 48 |
12396448 | Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission. | 2002 Oct 10 |
1 |
| 49 |
11145893 | Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA. | 2001 Jan 5 |
1 |
| 50 |
10400763 | Activated memory CD4(+) T helper cells repopulate the intestine early following antiretroviral therapy of simian immunodeficiency virus-infected rhesus macaques but exhibit a decreased potential to produce interleukin-2. | 1999 Aug |
4 |